title: Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.
abstract: Various approaches have been used to model human Graves' disease in mice, including transfected fibroblasts, and plasmid or adenoviral immunisations with the extracellular A subunit of the human thyrotropin receptor (TSHR). Some of these models were only observed for a short time period or were self-limiting. A long-term model for human Graves' disease was established in mice using continuing immunisations (4-weekly injections) with recombinant adenovirus expressing TSHR. Generation of TSHR binding cAMP-stimulatory antibodies, thyroid enlargement and alterations, elevated serum thyroxin levels, tachycardia and cardiac hypertrophy were maintained for at least 9 months in all Ad-TSHR-immunised mice. Here, we show that these mice suffer from orbitopathy, which was detected by serial orbital sectioning and histomorphometry. Attempts to treat established Graves' disease in preclinical mouse model studies have included small molecule allosteric antagonists and specific antagonist antibodies which were isolated from hypothyroid patients. In addition, novel peptides have been conceived which mimic the cylindrical loops of the TSHR leucine-rich repeat domain, in order to re-establish tolerance toward the antigen. Here, we show preliminary results that one set of these peptides improves or even cures all signs and symptoms of Graves' disease in mice after six consecutive monthly injections. First beneficial effects were observed 3-4 months after starting these therapies. In immunologically naïve mice, administration of the peptides did not induce any immune response.
authors.affiliation: Procorde (Advancecor), Fraunhoferstrasse 9a, 82152, Martinsried, Germany. ungerer@procorde.com.
authors.forename: Martin
authors.initials: M
authors.lastname: Ungerer
authors.affiliation: Procorde (Advancecor), Fraunhoferstrasse 9a, 82152, Martinsried, Germany.
authors.forename: Julia
authors.initials: J
authors.lastname: Faßbender
authors.affiliation: Procorde (Advancecor), Fraunhoferstrasse 9a, 82152, Martinsried, Germany.
authors.forename: Zhongmin
authors.initials: Z
authors.lastname: Li
authors.affiliation: Procorde (Advancecor), Fraunhoferstrasse 9a, 82152, Martinsried, Germany.
authors.forename: Götz
authors.initials: G
authors.lastname: Münch
authors.affiliation: Procorde (Advancecor), Fraunhoferstrasse 9a, 82152, Martinsried, Germany.
authors.forename: Hans-Peter
authors.initials: HP
authors.lastname: Holthoff
mesh_terms: D000818:Animals; D004195:Disease Models, Animal; D006111:Graves Disease / Q000276:immunology* / Q000473:pathology; D007108:Immune Tolerance / Q000276:immunology*; D007114:Immunization; D051379:Mice; D009916:Orbital Diseases / Q000209:etiology / Q000276:immunology / Q000473:pathology; D011989:Receptors, Thyrotropin / Q000276:immunology*
chemical_list: D011989:Receptors, Thyrotropin
keywords: Autoimmunity; Graves’ disease; Peptides; Thyreotropin receptor; Tolerance